Navigation Links
Bolli Becomes New Editor-In-Chief of Circulation Research
Date:7/29/2009

PHILADELPHIA, July 29 /PRNewswire/ -- Roberto Bolli, M.D., is the new editor-in-chief of Circulation Research: Journal of the American Heart Association.

Bolli, chief of the Division of Cardiovascular Medicine and director of the Institute of Molecular Cardiology at the University of Louisville in Kentucky, will assume his role with the July 31 issue of the journal, posted online on July 30.

"It is an honor and a privilege to serve as editor-in-chief of this prestigious and critically important scientific journal," Bolli said. "In an era of incredibly rapid progress in cardiovascular medicine, the scientific discoveries leading to the next generation of clinical advances will appear first in the pages of Circulation Research."

Circulation Research, the official bi-weekly journal of the American Heart Association's Council on Basic Cardiovascular Sciences, is devoted to new basic science research from all disciplines related to cardiac and vascular biology and cardiovascular disease. The journal presents the most significant research from fields including cellular biology, molecular biology and molecular genetics, as well as biochemistry, biophysics, pathology, physiology and pharmacology.

Each issue of Circulation Research features reports on molecular medicine, cellular biology and integrative physiology. Respected investigators and clinicians present editorials and authoritative reviews on topics of special interest, providing readers with indispensable perspectives on new and emerging scientific concepts.

"We are on the threshold of amazing new discoveries in areas such as regenerative cardiology, embryonic development of the heart and blood vessels and the genetics of cardiovascular disease," Bolli said. "My associate editors and I are eager to meet the challenge of guiding the journal through the next phase in its evolution."

The July 31 issue of Circulation Research will include a cover redesign as part of numerous upcoming changes. The journal is published by Lippincott Williams & Wilkins, a division of Wolters Kluwer Health.

The journal's Web site, http://circres.ahajournals.org, has also been redesigned and streamlined, facilitating browsing and quick access to featured articles and "Online First" papers. Subscribers and readers have access to the journal's expanded online archive, including the complete history of the journal from the 1950s to the present.

With an impact factor of 9.989, Circulation Research is ranked No. 3 among 78 journals in cardiac and cardiovascular systems, No. 2 among 56 journals in peripheral vascular disease and No. 3 among 62 journals in hematology, according to the 2008 ISI Journal Citation Reports(R), published by Thomson Scientific.

"The breathtaking pace of new discoveries in the basic science of cardiology makes the appointment of a new editor of Circulation Research a noteworthy event," said Donna Arnett, Ph.D., chairperson of the American Heart Association's Scientific Publishing Committee. "We recognize the service and achievement of Dr. Eduardo Marban, outgoing editor-in-chief, and we are certain that Dr. Bolli and his team will continue to build on the journal's long history of scientific excellence."

About the American Heart Association

Founded in 1924, the American Heart Association is the nation's oldest and largest voluntary health organization dedicated to building healthier lives, free of heart disease and stroke. These diseases, America's No. 1 and No. 3 killers, and all other cardiovascular diseases claim over 870,000 lives a year. In fiscal year 2006-07 the association invested more than $554 million in research, professional and public education, advocacy and community service programs to help all Americans live longer, healthier lives. To learn more, call 1-800-AHA-USA1 or visit americanheart.org.

About Lippincott Williams & Wilkins

Lippincott Williams & Wilkins (LWW) is a leading international publisher for healthcare professionals and students with nearly 300 periodicals and 1,500 books in more than 100 disciplines publishing under the LWW brand, as well as content-based sites and online corporate and customer services. LWW is part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health, pharmacy and the pharmaceutical industry.

Wolters Kluwer Health is a division of Wolters Kluwer, a leading global information services and publishing company. The company provides products and services for professionals in the health, tax, accounting, corporate, financial services, legal, and regulatory sectors. Wolters Kluwer had 2008 annual revenues of 3.4 billion euro ($4.9 billion), employs approximately 20,000 people worldwide, and maintains operations in over 35 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Amsterdam, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Visit www.wolterskluwer.com for information about our market positions, customers, brands, and organization.

NR09-1088 (Circ Res/Bolli)


'/>"/>
SOURCE American Heart Association
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Crdentia Promotes Kevin Bollin to Area Manager of Austin, Dallas and San Antonio, Texas, Markets
2. MRI finds breast cancer before it becomes dangerous
3. MinuteClinic Becomes Participating Provider with Assurant Health
4. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
5. Michael Moores SiCKO Becomes the Third Highest Grossing Documentary of All Time Surpassing An Inconvenient Truth
6. SMART Association Becomes Healthcare Council Member of Smart Card Alliance
7. Smurfit-Stones Hodge, LA, Mill Becomes First to Achieve Safety Milestone
8. Dr. Dan L. Fortenbacher, O.D., FCOVD, Becomes 29th President of College of Optometrists in Vision Development (COVD); Unveils 7-Part Development Plan for Ongoing Growth
9. PharmMD Becomes an ASCP MTM Provider Partner
10. Outcomes Pharmaceutical Health Care(r) Becomes an ASCP MTM Provider Partner
11. Pharm MD Solutions Becomes an ASCP MTM Provider Partner
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... Rhinebeck, NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of ... of companies that call for a minimum wage raise to $12 an hour by 2020 ... wage. This will restore the lost value of the minimum wage, assure the wage floor ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... actively feeding the Frederick area economy by obtaining investment capital for emerging technology ... past 2½ years that have already resulted in more than a million dollars ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
Breaking Medicine Technology: